首页> 外文期刊>Canadian journal of anesthesia: Journal canadien d'anesthesie >Anesthetic considerations in a patient with visceral leishmaniasis.
【24h】

Anesthetic considerations in a patient with visceral leishmaniasis.

机译:内脏利什曼病患者的麻醉注意事项。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To describe the anesthetic problems in a patient with visceral leishmaniasis undergoing general anesthesia. CLINICAL FEATURES: A 17-yr-old man with visceral leishmaniasis was booked for emergency appendectomy. He received parentral sodium stibogluconate 600 mg per day. The patient was pale, afebrile and had hepatosplenomegaly. Preoperative investigations showed a hemoglobin of 6.2 g.dL(-1), platelet count of 80 x 10(9).L(-1) and serum albumin of 2.1 g.dL(-1). The electrocardiogram and chest x-ray were normal. Anesthesia was induced with 100 microg fentanyl and 50 mg propofol iv and tracheal intubation was facilitated with 3 mg vecuronium iv. Maintenance of anesthesia was done with intermittent positive pressure ventilation using 50% nitrous oxide and 0.4% isoflurane in oxygen. Reversal of neuromuscular blockade was achieved with 1.0 mg neostigmine and 0.2 mg atropine iv. 50 mg tramadol iv every six hours was used for postoperative analgesia. The perioperative course was uneventful. CONCLUSION: Patients with visceral leishmaniasis have problems unique to them that may influence the anesthetic management. Of particular concern to an anesthesiologist are the presence of hematological abnormalities (anemia, leukopenia, thrombocytopenia), and hypoalbuminic malnutrition. The combination of low hemoglobin and thrombocytopenia may necessitate blood component therapy perioperatively. Drugs affecting coagulation should be used judiciously. Hypoalbuminemia may adversely affect the pharmacokinetics of agents that are highly protein bound. The anesthetic management in a patient with visceral leishmaniasis may be further complicated by the presence of coexisting infections like pneumonia and tuberculosis. Leishmaniasis is a recognized complication of infection with human immunodeficiency virus.
机译:目的:描述接受全身麻醉的内脏利什曼病患者的麻醉问题。临床特征:一名内脏利什曼病的17岁男性被预定进行急诊阑尾切除术。他每天接受600毫克的亲本司他葡糖酸钠。病人面色苍白,无发热,肝脾肿大。术前检查显示血红蛋白为6.2 g.dL(-1),血红蛋白为6.2 g.dL(-1),血小板计数为80 x 10(9).L(-1)。心电图和胸部X线检查正常。用100微克芬太尼和50毫克丙泊酚iv诱导麻醉,并用3毫克维库溴铵iv促进气管插管。使用50%的一氧化二氮和0.4%的异氟烷​​在氧气中进行间歇正压通气来维持麻醉。用1.0 mg新斯的明和0.2 mg阿托品静脉注射可逆转神经肌肉阻滞。每六个小时静脉注射50 mg曲马多用于镇痛。围手术期过程顺利。结论:内脏利什曼病患者存在独特的问题,可能会影响麻醉管理。麻醉医师特别关注的是血液学异常(贫血,白细胞减少症,血小板减少症)和白蛋白营养不良。低血红蛋白和血小板减少症的结合可能需要围手术期进行血液成分治疗。应谨慎使用影响凝血的药物。低白蛋白血症可能会对高度蛋白结合的药物的药代动力学产生不利影响。内脏利什曼病患者的麻醉管理可能由于并存的感染(如肺炎和肺结核)而进一步复杂化。利什曼病是公认的人类免疫缺陷病毒感染的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号